Amphastar Pharmaceuticals, Inc. (AMPH) swung to a net loss for the quarter ended Dec. 31, 2016. The company has made a net loss of $2.74 million, or $ 0.06 a share in the quarter, against a net profit of $7.53 million, or $0.16 a share in the last year period. On the other hand, adjusted net income for the quarter stood at $0.55 million, or $0.01 a share compared with $9.07 million or $0.19 a share, a year ago. Revenue during the quarter dropped 17.38 percent to $63.54 million from $76.91 million in the previous year period. Gross margin for the quarter contracted 1172 basis points over the previous year period to 31.41 percent. Operating margin for the quarter stood at negative 7.10 percent as compared to a positive 18.68 percent for the previous year period.
Operating loss for the quarter was $4.51 million, compared with an operating income of $14.37 million in the previous year period.
Disclaimer: Please note that this is an auto-generated article. IRIS does not guarantee the accuracy, adequacy or completeness of any information and is not responsible for any errors or omissions or for the results obtained from the use of such information. IRIS especially states that it has no financial liability whatsoever to any user on account of the use of information provided on its website. For queries contact: [email protected]